They move the stethoscope around to listen to the heart, lungs, abdomen. Front and back, check where there's congestion / potential infection - in specific locations.
Resapp just listens to a cough, it's no wonder the most recent clinical trials have significantly different results to previous ones. It's comparable to listening to farts to determine stomach problems, there is simply not enough evidence in a cough with enough accuracy to make any meaningful diagnosis, other than, they have a cough.
- Forums
- ASX - By Stock
- RAP
- Ann: Results from Data Confirmation Study
Ann: Results from Data Confirmation Study, page-273
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online